Who owns Amicus Therapeutics?

Key details on Amicus Therapeutics (Ticker: FOLD)

Who owns Amicus Therapeutics?

Is FOLD a good stock to own? Find out who bought Amicus Therapeutics, who sold Amicus Therapeutics (FOLD) stock, and who holds a large position in Amicus Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 18.73M $181.73M Dec. 31, 2015
Perceptive Advisors 15.24M $147.82M Dec. 31, 2015
Redmile 10.28M $99.72M Dec. 31, 2015
Sectoral Asset Management 7.97M $77.34M Dec. 31, 2015
Vanguard 6.23M $60.41M Dec. 31, 2015
T. Rowe Price Associates 5.93M $57.51M Dec. 31, 2015
NEA Management Company 5.65M $47.03M Dec. 31, 2014
BlackRock Fund Advisors 5.36M $52.00M Dec. 31, 2015
STATE STREET CORPORATION 5.16M $50.02M Dec. 31, 2015
Jennison Associates 5.14M $43.44M March 31, 2016
Janus Capital Management 5.09M $49.42M Dec. 31, 2015
CITADEL ADVISORS 4.28M $59.88M Sept. 30, 2015
Millennium Management 3.73M $52.25M Sept. 30, 2015
Palo Alto Investors 3.55M $34.45M Dec. 31, 2015
venBio Select Advisor 3.52M $34.10M Dec. 31, 2015
RS INVESTMENT MANAGEMENT 3.49M $33.84M Dec. 31, 2015
D. E. Shaw & Co 3.43M $33.23M Dec. 31, 2015
BlackRock Institutional Trust Company, N.A. 2.97M $28.85M Dec. 31, 2015
FRAZIER MANAGEMENT 2.92M $28.31M Dec. 31, 2015
UBS GLOBAL ASSET MANAGEMENT AMERICAS 2.46M $5.08M March 31, 2014
HealthCor Management 2.28M $6.11M Dec. 31, 2012
ALLIANCEBERNSTEIN 2.19M $21.27M Dec. 31, 2015
Emerald Mutual Fund Advisers, Trust 2.05M $17.35M March 31, 2016
Franklin Resources 1.97M $19.10M Dec. 31, 2015
Emerald Advisers 1.90M $16.04M March 31, 2016
Morgenthaler Management Partners IX 1.78M $17.30M Dec. 31, 2015
Bridger Management 1.71M $9.01M March 31, 2012
Dr. Jeffrey R. Jay, M.D 1.64M $5.64M Dec. 31, 2011
GOLDMAN SACHS 1.58M $15.35M Dec. 31, 2015
Longwood Capital Partners 1.50M $14.58M Dec. 31, 2015
Balyasny Asset Management 1.48M $12.35M Dec. 31, 2014